Virtual Tumors Point to New Drug Combinations for Hard-to-Treat Lung Cancer Mutations
A new quantitative systems pharmacology model spanning all three classes of BRAF-mutant lung cancer predicts that MEK-ERK inhibitor combinations can ...
A new quantitative systems pharmacology model spanning all three classes of BRAF-mutant lung cancer predicts that MEK-ERK inhibitor combinations can ...
An integrative multi-omics study reveals how loss of the chromatin factor ARID1A rewires receptor and kinase signaling in melanoma, driving ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine